Form 8-K - Current report:
SEC Accession No. 0001641172-25-002581
Filing Date
2025-04-03
Accepted
2025-04-03 16:31:19
Documents
69
Period of Report
2025-04-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39179
2 ex99-1.htm EX-99.1 70636
3 form8-k_001.jpg GRAPHIC 17104
4 ex99-1_001.jpg GRAPHIC 201337
5 ex99-1_002.jpg GRAPHIC 247675
6 ex99-1_003.jpg GRAPHIC 137362
7 ex99-1_004.jpg GRAPHIC 211499
8 ex99-1_005.jpg GRAPHIC 224784
9 ex99-1_006.jpg GRAPHIC 134096
10 ex99-1_007.jpg GRAPHIC 178578
11 ex99-1_008.jpg GRAPHIC 218836
12 ex99-1_009.jpg GRAPHIC 162526
13 ex99-1_010.jpg GRAPHIC 112266
14 ex99-1_011.jpg GRAPHIC 166181
15 ex99-1_012.jpg GRAPHIC 177952
16 ex99-1_013.jpg GRAPHIC 177896
17 ex99-1_014.jpg GRAPHIC 117046
18 ex99-1_015.jpg GRAPHIC 170458
19 ex99-1_016.jpg GRAPHIC 219184
20 ex99-1_017.jpg GRAPHIC 198754
21 ex99-1_018.jpg GRAPHIC 191485
22 ex99-1_019.jpg GRAPHIC 159304
23 ex99-1_020.jpg GRAPHIC 169761
24 ex99-1_021.jpg GRAPHIC 220873
25 ex99-1_022.jpg GRAPHIC 190563
26 ex99-1_023.jpg GRAPHIC 125562
27 ex99-1_024.jpg GRAPHIC 191237
28 ex99-1_025.jpg GRAPHIC 134187
29 ex99-1_026.jpg GRAPHIC 186383
30 ex99-1_027.jpg GRAPHIC 202243
31 ex99-1_028.jpg GRAPHIC 137719
32 ex99-1_029.jpg GRAPHIC 211112
33 ex99-1_030.jpg GRAPHIC 204365
34 ex99-1_031.jpg GRAPHIC 154338
35 ex99-1_032.jpg GRAPHIC 147253
36 ex99-1_033.jpg GRAPHIC 128999
37 ex99-1_034.jpg GRAPHIC 134776
38 ex99-1_035.jpg GRAPHIC 165831
39 ex99-1_036.jpg GRAPHIC 91042
40 ex99-1_037.jpg GRAPHIC 130178
41 ex99-1_038.jpg GRAPHIC 153286
42 ex99-1_039.jpg GRAPHIC 76246
43 ex99-1_040.jpg GRAPHIC 163227
44 ex99-1_041.jpg GRAPHIC 255424
45 ex99-1_042.jpg GRAPHIC 207534
46 ex99-1_043.jpg GRAPHIC 266880
47 ex99-1_044.jpg GRAPHIC 272231
48 ex99-1_045.jpg GRAPHIC 173992
49 ex99-1_046.jpg GRAPHIC 148558
50 ex99-1_047.jpg GRAPHIC 207808
51 ex99-1_048.jpg GRAPHIC 168999
52 ex99-1_049.jpg GRAPHIC 154305
53 ex99-1_050.jpg GRAPHIC 191323
54 ex99-1_051.jpg GRAPHIC 160791
55 ex99-1_052.jpg GRAPHIC 175773
56 ex99-1_053.jpg GRAPHIC 118852
57 ex99-1_054.jpg GRAPHIC 132820
  Complete submission text file 0001641172-25-002581.txt   13229492

Data Files

Seq Description Document Type Size
58 XBRL SCHEMA FILE lpcn-20250403.xsd EX-101.SCH 3014
59 XBRL LABEL FILE lpcn-20250403_lab.xml EX-101.LAB 34239
60 XBRL PRESENTATION FILE lpcn-20250403_pre.xml EX-101.PRE 22358
71 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3685
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 25810062
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)